U014 Using Artificial Intelligence for Rare Dermatologic Diseases: Getting the Right Patients the Right Treatment at the Right Time
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Since inception, the AAD's clinical data registry, DataDerm, has collected data on nearly 60 million patient encounters with the goal of promoting the highest standards in clinical practice and research, including addressing disparities in dermatologic care. Session speakers will describe how findings from DataDerm are being used to advance the understanding of rare dermatologic diseases. An innovative artificial intelligence tool, OM1’s Patient Finder, allows identification of likely undiagnosed patients and will be discussed. Experts will describe how predictive analytics can advance educational efforts to decrease patient suffering by accelerating diagnosis and reducing inappropriate, costly treatment.
LEARNING OBJECTIVES
Describe how registry data can be leveraged with artificial intelligence to gain a greater understanding of underdiagnosed diseases to subsequently develop education and awareness initiatives.
Review the power of predictive analytics in identifying undiagnosed patients to reduce patient suffering and unnecessary treatment costs related to misdiagnosis.
SCHEDULE
12:30 PM
Overview of DataDerm
Robert Swerlick, MD, FAAD
12:35 PM
Overview of Patient Finder and OM1’s collaboration with AAD
Joseph Zabinski, PhD
12:50 PM
How Patient Finder was used with Generalized pustular psoriasis (GPP)
Marta Jane Van Beek, MD, MPH, FAAD
1:05 PM
Patient Finder for Hidradenitis suppurativa (HS)
Steven Daniel Daveluy, MD, FAAD
1:20 PM
Question and Answer
SPEAKERS
Steven Daniel Daveluy, MD, FAAD
Robert Swerlick, MD, FAAD
Marta Jane Van Beek, MD, MPH, FAAD
Joseph Zabinski, PhD
HANDOUTS
SPEAKER DISCLOSURES
Steven Daniel Daveluy, MD, FAAD
AbbVie – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Incyte – Advisory Board(Honoraria); Insmed – Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Investigator(Grants/Research Funding); Novartis – Speaker(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); UCB – Consultant(Fees), Investigator(Grants/Research Funding), Speaker(Honoraria);
Robert Swerlick, MD, FAAD
No financial relationships exist with ineligible companies.
Marta Jane Van Beek, MD, MPH, FAAD
No financial relationships exist with ineligible companies.
Joseph Zabinski, PhD
No financial relationships exist with ineligible companies.